Skip to main content
Veterinary Medicines

Iwermektyna - pasta dla koni 18,7 mg/g Pasta doustna

Authorised
  • Ivermectin

Product identification

Medicine name:
Iwermektyna - pasta dla koni 18,7 mg/g Pasta doustna
Active substance:
  • Ivermectin
Target species:
  • Horse
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ivermectin
    1.87
    gram(s)
    /
    100.00
    gram(s)
Pharmaceutical form:
  • Oral paste
Withdrawal period by route of administration:
  • Oral use
    • Horse
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AA01
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Przedsiebiorstwo Farmaceutyczne Okoniewscy Vetos Farma Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Przedsiebiorstwo Farmaceutyczne Okoniewscy Vetos Farma Sp. z o.o.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1514
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 15/11/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."